BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1421702)

  • 1. [Second cancers after treatment of Hodgkin's disease: experience at the International Database on Hodgkin's disease (IDHD)].
    Henry-Amar M
    Bull Cancer; 1992; 79(4):389-91. PubMed ID: 1421702
    [No Abstract]   [Full Text] [Related]  

  • 2. Incidence of second solid cancer in patients after treatment of Hodgkin's disease.
    Glanzmann C; Veraguth A; Lütolf UM
    Strahlenther Onkol; 1994 Mar; 170(3):140-6. PubMed ID: 8160093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's disease: treatment and secondary neoplasms.
    Kaiser HE
    In Vivo; 1994; 8(5):733-6. PubMed ID: 7727720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
    Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Late effects of treatment for childhood Hodgkin's disease.
    Mirer FE
    N Engl J Med; 1996 Aug; 335(5):352; author reply 353-5. PubMed ID: 8668222
    [No Abstract]   [Full Text] [Related]  

  • 6. Late effects of treatment for childhood Hodgkin's disease.
    Travis LB; Curtis RE; Boice JD
    N Engl J Med; 1996 Aug; 335(5):352-3. PubMed ID: 8668223
    [No Abstract]   [Full Text] [Related]  

  • 7. [Late complications of treatment for Hodgkin's disease in children and adolescents].
    Balwierz W; Moryl-Bujakowska A
    Przegl Lek; 2006; 63(1):31-6. PubMed ID: 16892897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Second neoplasms in Hodgkin's disease: current controversies.
    Zarrabi MH; Rosner F
    Hematol Oncol Clin North Am; 1989 Jun; 3(2):303-18. PubMed ID: 2663829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary malignancies after treatment for indolent non-Hodgkin's lymphoma: a 16-year follow-up study.
    Sacchi S; Marcheselli L; Bari A; Marcheselli R; Pozzi S; Luminari S; Lombardo M; Buda G; Lazzaro A; Gobbi PG; Stelitano C; Morabito F; Quarta G; Brugiatelli M
    Haematologica; 2008 Mar; 93(3):398-404. PubMed ID: 18268277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid nodules and survivors of Hodgkin's disease.
    Oeffinger KC; Sklar CA; Hudson MM
    Am Fam Physician; 2003 Sep; 68(6):1016, 1018-9; discussion 1019. PubMed ID: 14524392
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
    Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
    Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary solid tumors after Hodgkin's disease radiotherapy; experience at the Gustave Roussy Institute].
    Cosset JM; Henry-Amar M; Dietrich PY; Socié G; Girinsky T; Hayat M; Tubiana M
    Bull Cancer; 1992; 79(4):387-8. PubMed ID: 1421701
    [No Abstract]   [Full Text] [Related]  

  • 13. [Second cancers in hematologic malignancies (epidemiologic observations from a 20-year period)].
    Jakó J; Szerafin L; Nagy P
    Orv Hetil; 2005 Mar; 146(10):461-9. PubMed ID: 15835344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Janeway lecture. Hodgkin's disease--finding the balance between cure and late effects.
    Donaldson SS; Hancock SL; Hoppe RT
    Cancer J Sci Am; 1999; 5(6):325-33. PubMed ID: 10606471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second cancers after radiotherapy and chemotherapy for early stages of Hodgkin's disease.
    Henry-Amar M
    J Natl Cancer Inst; 1983 Nov; 71(5):911-6. PubMed ID: 6580491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid second cancers following Hodgkin's disease.
    Tucker MA
    Hematol Oncol Clin North Am; 1993 Apr; 7(2):389-400. PubMed ID: 8468272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary malignancies in late periods after chemoradiotherapy for lymphogranulomatosis in children].
    Parkhomenko RA; Shcherbenko OI; Zelinskaia NI; Snigireva RIa; Khalil' EF; Ardatova GV; Chazova NL
    Vestn Rentgenol Radiol; 2008; (2-3):7-9. PubMed ID: 21337756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Second malignancies complicating Hodgkin's disease: a Southwest Oncology Group 10-year followup.
    Coltman CA; Dixon DO
    Cancer Treat Rep; 1982 Apr; 66(4):1023-33. PubMed ID: 7074630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New cancer disease after treatment of Hodgkin's disease].
    Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Kvaløy SO; Høst H; Abrahamsen AF
    Tidsskr Nor Laegeforen; 1993 Sep; 113(23):2903-5. PubMed ID: 8236191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
    Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
    Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.